Markus Y Mapara, MD

Roshan P. Shah, MD, JD, specializes in hip and knee reconstruction using minimally invasive techniques for less pain and faster recovery times. He believes there are many valuable pain-relieving treatments that do not involve surgery. When an operation is needed, he embraces careful surgical techniques with attention to the biological, anatomical, and mechanical restoration that is critical for a pain-free return of function. Dr. Shah has a particular interest in complex primary and revision hip and knee replacements, as well as associated fractures and infections. As Director of Complex Adult Hip and Knee Reconstruction at Columbia University, he has reconstructed failed total hips and knees using sophisticated techniques and technologies. He has successfully treated patients from across the United States and neighboring countries, finding solutions to problems that stump others. Dr. Shah has made several contributions to research, having published 40 peer-reviewed articles, textbook chapters, and editorials, in addition to giving more than 30 scientific presentations. He served as editor of the University of Pennsylvania Orthopaedic Journal and the Yale Journal of Health Law, Policy, and Ethics. He was also an associate editor for the Stanford Law and Policy Review. Dr. Shah has been honored with multiple research awards, including 1st place at the Orthopaedic Research and Education Fund/Orthopaedic Research Society symposium, 2nd place at the Philadelphia Orthopaedic Society for Sports Medicine Research Symposium, the AO Kathryn Cramer Award, and the University of Pennsylvania Orthopaedic Journal Resident Recognition Award. He holds one provisional patent application for a patient safety device innovation. As a former Washington health policy fellow for both the American Academy of Orthopaedic Surgeons, and the American Association of Hip and Knee Surgeons, Dr. Shah continues to advocate for policies that serve patients, improve access to care, and support research and innovation. He was invited to speak on FDA regulatory issues and innovation within the field of orthopedic surgery at a meeting in Washington, D.C. A native of Camden, New York, he earned his B.A. in Chemistry from Dartmouth College, with additional concentrations in philosophy and public policy. He received his doctor of medicine degree from Yale University and his juris doctor degree from Stanford University. He was a resident in orthopedic surgery at the University of Pennsylvania, where he received the DeForest Willard Award for outstanding performance as an orthopedic senior resident and the Marvin E. Steinberg, MD Award in Adult Reconstruction for outstanding work in the field of adult reconstruction surgery. He also completed a post-doctoral research fellowship (in the field of tissue engineering for orthopaedic surgery applications) at the McKay Orthopaedic Research Laboratory. Before joining ColumbiaDoctors, he completed a fellowship in Adult Hip and Knee Reconstruction at Rush University. Additionally, he has travelled to Wrightington, England to study advanced principles of the hip at the Charnley Centre for Hip Surgery.

Joshua R. Sonett MD FACS is the Edward C. and Anne K. Weiskopf Professor of Surgical Oncology (in Surgery) at CUMC, Chief of General Thoracic Surgery and Director, The Price Family Center for Comprehensive Chest Care, Lung and Esophageal Center. He is instrumental in making the Thoracic Surgery section at Columbia University Medical Center one of the best in the U.S. and he is one of the youngest professors of surgery at a major academic institution in the United States. Dr. Sonett is best known for his work on the multidisciplinary treatment of lung and esophageal malignancies. Leading work in minimally invasive treatment of lung and esophageal cancer, Dr. Sonett and his team at Columbia are innovators in the development and teaching techniques of Video Assisted Thoracic Surgery (VATS) and Minimally Invasive Esophageal (MIE) surgery, allowing surgeons to incorporate these techniques into their daily practices. Dr. Sonett and his team make up one of the few programs in the country to employ a combination of maximal chemo and radiation and surgical therapies in the treatment of locally advanced lung malignancies. He is also a leader in multi-modality therapies for lung and esophageal cancers, and a pioneer in endo-bronchial palliation of benign and malignant airway stenosis. In the clinical area of lung transplantation, Dr. Sonett is best known for developing an extended-donor lung transplant criteria protocol. Extended donor criteria (EDC) applies to the use of organs that don't meet the usual criteria for transplantation due to various health problems, but are still healthy enough for a successful transplant (Liver MD 2006). Dr. Sonett and his team have been aggressively trying to alleviate the donor shortage by evaluating lungs that may be rejected from other centers (CS News 2005). Between 2001 and 2003, 53 percent of the lungs transplanted at NewYork-Presbyterian/Columbia were extended donor criteria lungs, with no difference in survival between EDC lung recipients and regular lung recipients. The Columbia programs has a 95% survival rate after one year and 83% after three years, which far surpasses the national average of 79% and 62% respectively (CS Lung News 2006). Dr. Sonett has been an invited speaker and principal and co- investigator of numerous clinical trials, author of numerous publications in renown journals such as the Journal of The American College of Cardiology, Annals of Thoracic Surgery, and the Journal of Heart and Lung Transplant, among many others. Dr. Sonett received his MD from Brody School of Medicine at East Carolina University Medical School, and completed his surgical residency at the University of Massachusetts, and Thoracic Fellowship at the University of Pittsburgh Medical Center. Professional Memberships include the New York Thoracic Society, The Society of Thoracic Surgeons, Fellow of the American College of Surgeons and member of the American Association for Thoracic Surgeons Dr. Sonett has received numerous award and honors including annual awards to America's Top Doctors, Castle Connolly America's Top Doctors for Cancer, New York Magazine's Best Doctors, the Barbara Neibauer Celebration of Life Award, Foundation for Thymic Cancer and the Humanitarian Award, Chesed of New Square.

Daniel Talmasov, MD, is a board-certified neurologist and psychiatrist in the Division of Aging and Dementia at Columbia University Irving Medical Center. After earning his M.D. at Stony Brook University, Dr. Talmasov completed his residency in psychiatry at Brigham and Women's Hospital / Harvard Medical School, followed by residency in neurology at NYU Langone / Bellevue Hospital Center, where he also served as chief resident. Dr. Talmasov then completed advanced training in Behavioral Neurology & Neuropsychiatry at Columbia University Irving Medical Center. Dr. Talmasov specializes in the treatment of patients with behavioral, cognitive, and emotional symptoms of neurodegenerative disease, including Frontotemporal Dementia and related disorders. He also provides neurobehavioral consultation for patients in the Eleanor and Lou Gehrig ALS Center and the Huntington's Disease Society Center of Excellence at Columbia.